CD1d-lipid complex (CD1d)

The **CD1d-lipid complex** is a heterodimeric antigen-presenting receptor composed of the CD1d heavy chain and β2-microglobulin, structurally similar to MHC class I molecules[1][4][5][9]. Unlike classical MHC receptors, CD1d presents lipid and glycolipid antigens, rather than peptides, to invariant natural killer T (iNKT) cells, thereby initiating rapid cytokine secretion that bridges innate and adaptive immune responses[4][9]. CD1d is widely expressed on antigen-presenting cells (e.g., dendritic cells, B cells, macrophages), trafficking between the cell surface and endosomal compartments to sample self- and microbial lipid antigens[9][3][5]. Its antigen-binding groove is shaped to tightly accommodate hydrophobic lipid chains while exposing hydrophilic headgroups for TCR recognition, with the flexibility to bind a wide range of endogenous and exogenous lipid ligands, including α-galactosylceramide (a potent NKT cell agonist), sulfatide, and bacterial glycolipids[1][9][3][5]. CD1d-mediated NKT cell activation regulates immune responses in cancer, autoimmunity, infection, and inflammation[1][2][9]. Additionally, CD1d influences macrophage lipid metabolism and inflammatory priming, revealing metabolic-immune circuit functions not solely attributable to antigen presentation[2]. Therapeutic targeting of the CD1d-lipid complex includes synthetic lipid ligands designed to activate or modulate NKT cell responses, but safety concerns include potential for immune overstimulation and autoimmunity due to broad ligand reactivity[7][8].

Other names

CD1dCD1d-β2-microglobulinCD1d/glycolipid complexCD1d antigen-presenting molecule

Activation of invariant NKT (iNKT) cells via presentation of lipid antigens to T cell receptors Modulation of cytokine secretion (e.g., IFN-γ, IL-4) Regulation of immune tolerance and inflammation